Joincare Pharmaceutical Group Industry Co Ltd Cash Flow Quality Index
Joincare Pharmaceutical Group Industry Co Ltd cash flow quality index. Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Cash Flow Quality Index of 3.56x as of September 2025. Operating cash flow of CN¥1.09 Billion exceeds net income of CN¥306.27 Million, indicating high earnings quality where cash backs reported profits. See Joincare Pharmaceutical Group Industry C (600380) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Cash flow quality index of Joincare Pharmaceutical Group Industry Co Ltd from 1999 to 2025. Historical Cash Flow Quality Index for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 600380 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Joincare Pharmaceutical Group Industry Co Ltd Cash Flow Quality Index by Year (1999–2025)
Joincare Pharmaceutical Group Industry Co Ltd cash flow quality index by year from 1999 to 2025. Year-by-year earnings quality comparison for Joincare Pharmaceutical Group Industry Co Ltd. For the full cash flow conversion analysis, see 600380 cash flow metrics.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.91x | CN¥3.89 Billion | CN¥1.34 Billion | ▲ +139.0% |
| 2024 | 1.22x | CN¥3.64 Billion | CN¥2.98 Billion | ▼ -55.2% |
| 2023 | 2.72x | CN¥3.93 Billion | CN¥1.44 Billion | ▲ +98.1% |
| 2022 | 1.37x | CN¥3.98 Billion | CN¥2.89 Billion | ▲ +40.1% |
| 2021 | 0.98x | CN¥2.56 Billion | CN¥2.61 Billion | ▼ -16.4% |
| 2020 | 1.17x | CN¥3.02 Billion | CN¥2.58 Billion | ▼ -6.1% |
| 2019 | 1.25x | CN¥2.31 Billion | CN¥1.85 Billion | ▼ -0.1% |
| 2018 | 1.25x | CN¥1.83 Billion | CN¥1.46 Billion | ▲ +212.5% |
| 2017 | 0.40x | CN¥1.87 Billion | CN¥4.67 Billion | ▼ -76.3% |
| 2016 | 1.69x | CN¥1.64 Billion | CN¥974.41 Million | ▲ +9.7% |
| 2015 | 1.54x | CN¥1.26 Billion | CN¥821.79 Million | ▲ +7.4% |
| 2014 | 1.43x | CN¥979.46 Million | CN¥683.80 Million | ▲ +28.8% |
| 2013 | 1.11x | CN¥635.52 Million | CN¥571.49 Million | ▼ -33.1% |
| 2012 | 1.66x | CN¥734.36 Million | CN¥441.81 Million | ▲ +25.5% |
| 2011 | 1.32x | CN¥650.36 Million | CN¥491.04 Million | ▲ +20.3% |
| 2010 | 1.10x | CN¥1.11 Billion | CN¥1.00 Billion | ▲ +42.7% |
| 2009 | 0.77x | CN¥605.66 Million | CN¥784.54 Million | ▼ -95.8% |
| 2008 | 18.21x | CN¥455.01 Million | CN¥24.99 Million | ▲ +4254.9% |
| 2007 | 0.42x | CN¥429.26 Million | CN¥1.03 Billion | ▼ -95.5% |
| 2006 | 9.19x | CN¥272.50 Million | CN¥29.64 Million | ▲ +435.3% |
| 2005 | 1.72x | CN¥363.13 Million | CN¥211.45 Million | ▲ +41.4% |
| 2004 | 1.21x | CN¥241.71 Million | CN¥199.06 Million | ▲ +31.2% |
| 2003 | 0.93x | CN¥172.25 Million | CN¥186.14 Million | ▼ -32.7% |
| 2002 | 1.38x | CN¥236.13 Million | CN¥171.63 Million | ▲ +23.3% |
| 2001 | 1.12x | CN¥223.79 Million | CN¥200.62 Million | ▲ +7.1% |
| 2000 | 1.04x | CN¥171.61 Million | CN¥164.79 Million | ▼ -45.8% |
| 1999 | 1.92x | CN¥109.82 Million | CN¥57.20 Million | — |